Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  11,116 نتائج ل ""Antibodies, Monoclonal, Humanized""

فلترة النتائج

إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Efficacy and safety of pembrolizumab in cervical cancer: Protocol for systematic review and meta-analysis of randomized clinical trials.

  • Authors : Dantas DM; Graduate Program in Sciences Applied to Women's Health, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil.; de Souza ATB

Subjects: Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/drug therapy ; Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/pathology ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use

  • Source: PloS one [PLoS One] 2024 Oct 10; Vol. 19 (10), pp. e0312004. Date of Electronic Publication: 2024 Oct 10 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Adult-onset Still's disease masquerading as acute coronary syndrome: a case report and review of the literature.

  • Authors : Milne I; Penn State College of Medicine, Hershey, PA, USA.; Kanwar R

Subjects: Still's Disease, Adult-Onset*/Still's Disease, Adult-Onset*/Still's Disease, Adult-Onset*/diagnosis ; Still's Disease, Adult-Onset*/Still's Disease, Adult-Onset*/Still's Disease, Adult-Onset*/drug therapy ; Still's Disease, Adult-Onset*/Still's Disease, Adult-Onset*/Still's Disease, Adult-Onset*/complications

  • Source: Journal of medical case reports [J Med Case Rep] 2024 Oct 10; Vol. 18 (1), pp. 489. Date of Electronic Publication: 2024 Oct 10.Publisher: BioMed Central Country of Publication: England NLM ID: 101293382 Publication Model: Electronic Cited Medium: Internet ISSN: 1752-1947

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Node-sparing modified short-course Radiotherapy Combined with CAPOX and Tislelizumab for locally Advanced MSS of Middle and low rectal Cancer (mRCAT): an open-label, single-arm, prospective, multicentre clinical trial.

  • Authors : Cai C; Department of Colorectal and Anal Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.; Department of Colorectal Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Subjects: Rectal Neoplasms*/Rectal Neoplasms*/Rectal Neoplasms*/pathology ; Rectal Neoplasms*/Rectal Neoplasms*/Rectal Neoplasms*/therapy ; Rectal Neoplasms*/Rectal Neoplasms*/Rectal Neoplasms*/radiotherapy

  • Source: BMC cancer [BMC Cancer] 2024 Oct 09; Vol. 24 (1), pp. 1247. Date of Electronic Publication: 2024 Oct 09.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Longitudinal assessment of health-related quality of life in Japanese patients with advanced urothelial carcinoma receiving immune check point inhibitors.

  • Authors : Miyake M; Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan. .; Nishimura N

Subjects: Quality of Life* ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/therapeutic use ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/adverse effects

  • Source: Scientific reports [Sci Rep] 2024 Oct 04; Vol. 14 (1), pp. 23128. Date of Electronic Publication: 2024 Oct 04.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Preclinical comparison of prolgolimab, pembrolizumab and nivolumab.

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/pharmacology ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Nivolumab*/Nivolumab*/Nivolumab*/therapeutic use

  • Source: Scientific reports [Sci Rep] 2024 Oct 04; Vol. 14 (1), pp. 23136. Date of Electronic Publication: 2024 Oct 04.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Dupilumab-related Granulomatous Dermatitis.

  • Authors : Omer M; Department of Pathology, Warren Alpert Medical School of Brown University, Providence, Rhode Island.; Khadra SB

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Granuloma*/Granuloma*/Granuloma*/chemically induced

  • Source: Rhode Island medical journal (2013) [R I Med J (2013)] 2024 Oct 01; Vol. 107 (10), pp. 7-9. Date of Electronic Publication: 2024 Oct 01.Publisher: Rhode Island Medical Society Country of Publication: United States NLM ID: 101605827 Publication Model: Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Association Between Vedolizumab Treatment and Arthritis/Arthralgia in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.

  • Authors : Alves Halpern G; Deparment of Medicine, University Center of Volta Redonda, Volta Redonda, Rio de Janeiro (RJ), Brazil. .; Gomes C

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects ; Arthralgia*/Arthralgia*/Arthralgia*/chemically induced

  • Source: Journal of gastrointestinal and liver diseases : JGLD [J Gastrointestin Liver Dis] 2024 Sep 29; Vol. 33 (3), pp. 379-385. Date of Electronic Publication: 2024 Sep 29.Publisher:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Effectiveness and safety of canakinumab in cryopyrin-associated periodic syndrome: a retrospective study in China.

  • Authors : Zhu X; Department of Rheumatology and Immunology, Shenzhen Children's Hospital, 7019 Yitian Road, Shenzhen, China.; Fan J

Subjects: Cryopyrin-Associated Periodic Syndromes*/Cryopyrin-Associated Periodic Syndromes*/Cryopyrin-Associated Periodic Syndromes*/drug therapy ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects

  • Source: Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2024 Sep 27; Vol. 22 (1), pp. 87. Date of Electronic Publication: 2024 Sep 27.Publisher: BioMed Central Country of Publication: England NLM ID: 101248897 Publication Model: Electronic Cited Medium: Internet ISSN: 1546-0096

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer.

  • Authors : Manna M; Department of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5A2, Canada.; Department of Oncology, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.

Subjects: Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/pharmacology

  • Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Sep 21; Vol. 31 (9), pp. 5694-5708. Date of Electronic Publication: 2024 Sep 21.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Evaluation of adverse clinical outcomes in patients with inflammatory bowel disease receiving different sequences of first- and second-line biologic treatments: findings from ROTARY.

Subjects: Adalimumab*/Adalimumab*/Adalimumab*/therapeutic use ; Adalimumab*/Adalimumab*/Adalimumab*/adverse effects ; Infliximab*/Infliximab*/Infliximab*/therapeutic use

  • Source: BMC gastroenterology [BMC Gastroenterol] 2024 Sep 17; Vol. 24 (1), pp. 314. Date of Electronic Publication: 2024 Sep 17.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  11,116 نتائج ل ""Antibodies, Monoclonal, Humanized""